Daniel Lee

4PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 05, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.

William F Maguire, Daniel Lee, Chana Weinstock

|Oct 05, 2020
Rare Presentation of Metastatic Lobular Breast Carcinoma Involving Clear Cell Renal Cell Carcinoma.

Dayne Ashman, Gabriela Quiroga-Garza, Daniel Lee

Pageof 1